Thank you for correcting the text in this article. Your corrections improve Papers Past searches for everyone. See the latest corrections.

This article contains searchable text which was automatically generated and may contain errors. Join the community and correct any errors you spot to help us improve Papers Past.

Article image
Article image
Article image
Article image

NEW DRUG FOR HAY FEVER

ENCOURAGING RESULTS NEW YORK, June 7. Developmenb of a new drug called anthallan, which promises relief to hay fever sufferers after three weekff treatment, is announced in the bulletin of the New York Academy of Medicine. Anthallan,. which is taken in pill form at the rate of six a day, is said to attack the cau£e of the fever rather than the symptoms, and has already produced good results. . During experiments, 37 per cent, or patients showed complete recovery. The rest benefited in varying degrees-. It is not yet known how long patients will remain immune to hay fever, but doctors reported that some patients treated two years ago had suffered no recurrence. Anthallan may be used only under ca £e of a physician. . The new drug, which was developeo after 25 years’ experimentation by ur W. S. Loewe, a German refugee present teaching at Utah University* already is in production, and is pected to be available for general d»* tributlon shortly.

Permanent link to this item
Hononga pūmau ki tēnei tūemi

https://paperspast.natlib.govt.nz/newspapers/CHP19460619.2.78

Bibliographic details
Ngā taipitopito pukapuka

Press, Volume LXXXII, Issue 24905, 19 June 1946, Page 6

Word count
Tapeke kupu
167

NEW DRUG FOR HAY FEVER Press, Volume LXXXII, Issue 24905, 19 June 1946, Page 6

NEW DRUG FOR HAY FEVER Press, Volume LXXXII, Issue 24905, 19 June 1946, Page 6

Help

Log in or create a Papers Past website account

Use your Papers Past website account to correct newspaper text.

By creating and using this account you agree to our terms of use.

Log in with RealMe®

If you’ve used a RealMe login somewhere else, you can use it here too. If you don’t already have a username and password, just click Log in and you can choose to create one.


Log in again to continue your work

Your session has expired.

Log in again with RealMe®


Alert